Experimental drug reverses neural damage from traumatic brain injury

➡️A new study has shed light on how an experimental drug can reverse some of the neural damage associated with traumatic brain injury. The findings lay the groundwork for a future drug that could potentially prevent the cognitive deficits that follow on from concussion.
The findings come from a team of researchers at the University of California, San Francisco investigating a signaling pathway called the integrated stress response (ISR). This is a general cellular mechanism that is triggered in the presence of environmental stresses and often leads to a shutdown in the protein production facilities within cells.